Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00436306 · ClinicalTrials.gov registry record · Phase 4

Stage Matched Intervention to Increase Dual Method Use

A Phase 4 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Completed
Registry status
Phase 4
Development phase
550
Enrollment target

NCT00436306: Completed Phase 4 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

NCT00436306 is a Phase 4 study that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 550 participants, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00436306, a Phase 4 study, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

COMPLETED
Registry status
Phase 4
Development phase
550 participants
Enrollment target

Study Summary

The primary purpose of Project PROTECT was to evaluate two different intervention approaches that encourage young women to use dual methods of contraception. The individualized intervention is a computer assisted, fully-tailored, interactive intervention based on the transtheoretical model of behavior change. This intervention was compared to an enhanced standard care intervention that provided computer-based, non-tailored information and advice regarding the use of contraceptive methods. The two primary outcomes of this trial include: 1) a behavioral outcome: the reported use of dual methods of contraception; and 2) a biological outcome: an incident or recurrent STI or unintended pregnancy. The hypotheses of this trial were: 1) the individualized intervention will result in a greater increase in dual contraceptive use than the standard care approach; and 2) the individualized intervention would result in greater protection against incident or recurrent cases of sexually transmitted infections and unplanned pregnancies.

Primary Outcome

Outcome: ANY use of dual methods of contraception. Also evaluated consistent condom use.

Interventions

  • BEHAVIORAL Individualized Intervention
  • BEHAVIORAL Computer-based contraceptive information

Trial Details

FieldValue
Enrollment Target 550 participants
Start Date 1999-10
Est. Completion 2005-12
Phase Phase 4

What the finished NCT00436306 record still lists

NCT00436306 is an interventional study that assigns participants to a tested intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target.

The record links to 0 conditions, and to 2 interventions - of which Individualized Intervention is the first listed.

NCT00436306 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00436306 about?

NCT00436306 is a clinical study titled "Stage Matched Intervention to Increase Dual Method Use". The primary purpose of Project PROTECT was to evaluate two different intervention approaches that encourage young women to use dual methods of contraception. The individualized intervention is a computer assisted, fully-tailored, interactive intervention based on the transtheoretical model of behavi...

What is the current status of trial NCT00436306?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 550 participants. The study started on 1999-10. Estimated completion is 2005-12.

What interventions are being tested in trial NCT00436306?

The interventions under investigation include: Individualized Intervention (BEHAVIORAL), Computer-based contraceptive information (BEHAVIORAL).

Who is sponsoring clinical trial NCT00436306?

This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00436306's enrollment target sits among peer trials

550 152nd of 2000 higher than 1,848 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01852448 · 550 participants

    Genetics of Insulin and Incretins in Cystic Fibrosis

  • NCT02995252 · 550 participants

    The HOPE Study: Characterizing Patients With Hepatitis B and C

  • NCT03474913 · 550 participants

    Upright MRI for Prostate Cancer Screening

  • NCT04761120 · 550 participants

    Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00436306, the US trial registry maintained by the National Library of Medicine. NCT00436306 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.